Apitegromab Prevents Muscle Loss From GLP-1 Therapy
An investigational drug called apitegromab reduces lean muscle loss in patients using GLP-1 receptor agonists. Researchers published these findings…
An investigational drug called apitegromab reduces lean muscle loss in patients using GLP-1 receptor agonists. Researchers published these findings…